Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When you lose weight on tirzepatide, your body doesn't lose fat and muscle equally. Research shows that tirzepatide preferentially mobilizes fat tissue through dual GLP-1 and GIP receptor activation, while dietary protein and resistance exercise work together to protect your muscle mass during the weight loss process.
How Tirzepatide Targets Fat Versus Muscle During Weight Loss
Tirzepatide works through two distinct hormone pathways: GLP-1 and GIP receptors. The GIP pathway, unique to tirzepatide compared to semaglutide-only therapy, directly influences your body's fat storage and energy expenditure signals. Clinical trials show participants on tirzepatide experienced preferential fat loss, meaning the scale drop came predominantly from stored body fat rather than lean tissue breakdown.
Your muscles remain protected during tirzepatide treatment because the medication doesn't suppress muscle protein synthesis the way prolonged calorie restriction alone can. Instead, tirzepatide reduces your appetite and food intake, allowing your body to access stored fat for energy while you maintain your existing muscle through normal daily activity and exercise.
The Role of GIP Receptors in Fat Metabolism and Preservation
GIP receptor activation directly enhances your body's ability to break down stored fat for fuel. Unlike semaglutide, which targets only the GLP-1 pathway, tirzepatide's dual action includes GIP signaling that influences adipose tissue (fat cell) metabolism. This mechanism explains why tirzepatide users often report maintaining muscle strength and tone even as their weight decreases.
The GIP pathway also regulates your metabolic rate and energy expenditure after eating. When both GLP-1 and GIP receptors are activated together, they create a metabolic environment favorable to fat mobilization while sparing muscle. Studies comparing tirzepatide to GLP-1-only medications show tirzepatide users retain more lean body mass at equivalent weight loss percentages.
Protecting Muscle Mass While Using Tirzepatide
To maximize fat loss and minimize any potential lean tissue decline, prioritize adequate protein intake throughout your tirzepatide treatment. Muscle tissue requires sufficient amino acids to maintain its structure and function, especially when your overall calorie intake decreases. Aim for 0.7 to 1.0 gram of protein per pound of your goal body weight daily, distributed evenly across meals.
Resistance training and strength-building activities become your muscle's best ally during tirzepatide therapy. You don't need intense workouts—consistent, moderate-intensity resistance exercise two to three times weekly signals your body to preserve muscle tissue. Combined with adequate protein and tirzepatide's preferential fat-targeting action, this approach produces the body composition outcome most people desire: lower weight primarily from fat loss.
Genetic Factors That Influence Your Personal Fat and Muscle Response
Your individual response to tirzepatide's fat-targeting effects depends partly on genetic variations in the GLP-1 and GIP receptor genes, as well as genes controlling appetite and energy expenditure. The PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761 and GIPR rs1800437, which directly influence how efficiently your body processes tirzepatide and mobilizes stored fat.
Understanding your genetic peptide pathway predispositions allows PlexusDx clinicians to personalize your treatment approach. Someone with a specific GIP receptor variant might experience enhanced fat mobilization at lower doses, while others benefit from gradual titration to higher doses. This precision eliminates guesswork and optimizes your body composition outcomes from month one. The $99 genetic test becomes available after your first month of treatment, giving your care team actionable insights into your unique physiology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose muscle mass on tirzepatide?
Tirzepatide's dual GLP-1 and GIP action preferentially mobilizes fat tissue rather than breaking down muscle. With adequate protein intake and regular resistance exercise, most people maintain or even gain muscle while losing significant weight. Clinical data shows tirzepatide users retain more lean body mass than those using GLP-1-only medications at comparable weight loss levels.
How much protein do I need while taking tirzepatide?
Aim for 0.7 to 1.0 gram of protein per pound of your goal body weight, spread across three or four meals daily. This protein distribution supports muscle protein synthesis and helps your body prioritize fat loss. Adequate protein intake, combined with tirzepatide's metabolic effects, creates optimal conditions for preserving or building lean tissue.
Can I do resistance training while on tirzepatide?
Yes—resistance training is actually beneficial during tirzepatide therapy. Consistent, moderate-intensity strength work two to three times weekly preserves muscle mass and amplifies fat loss. Always consult your PlexusDx clinician before starting a new exercise program, especially if you have any underlying health conditions.
What's the difference between tirzepatide and semaglutide for fat loss?
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide targets only GLP-1 receptors. This dual action makes tirzepatide more effective at preferentially targeting fat tissue and preserving muscle. PlexusDx offers Compounded Tirzepatide Injection starting at $249/mo, with your dose able to increase while your price remains flat.
How does the PlexusDx Precision Peptide Genetic Test help with body composition?
The test analyzes 14 peptide pathways and 150+ genetic insights, including GLP1R and GIPR variants that directly influence fat mobilization and muscle metabolism. These results help PlexusDx clinicians personalize your tirzepatide protocol for optimal fat loss and muscle preservation. The $99 test becomes available after your first month of treatment.
Is tirzepatide from PlexusDx FDA-approved?
PlexusDx's Compounded Tirzepatide Injection is prepared by licensed 503A compounding pharmacies and is not FDA-approved as a compounded medication. However, tirzepatide (brand name Mounjaro) is FDA-approved for diabetes and has substantial clinical evidence for weight management in those with overweight or obesity.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Semaglutide and Gallstones: What You Need to Know for Your Weight Loss Journey
Do You Gain Back the Weight After Stopping Ozempic? Exploring the Reality of Weight Regain